A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Small Intestine Cancer Bookmark and Share

Small Intestine Cancer

Although small intestine cancer is relatively rare in United States, it can be challenging to diagnose and treat. Thus, early detection and prompt medical care is crucial for optimal outcomes with minimal side effects.
 
City of Hope has one of the most experienced small intestine cancer programs in the United States, with a multidisciplinary team that takes an integrated approach to detecting and treating cancer of the small intestine. This includes using advanced technologies and specialized techniques such as:

  • minimally-invasive, robotically-assisted techniques for complex surgeries that can remove tumors with less discomfort, reduced risk of complications and shorter recovery times
  • highly precise radiation therapy that can target hard-to-resect tumors with minimal exposure to surrounding normal tissue
  • targeted drugs and drug combinations that can treat advanced small intestine cancer with greater effectiveness and fewer side effects, compared to traditional chemotherapy
  • combination regimens integrating surgery, radiation, chemotherapy and immunotherapy for maximum cancer-fighting effectiveness
 
Additionally, City of Hope patients have access to our extensive team of supportive care experts — including dieticians, supportive medicine physicians and rehabilitation specialists. Working closely with the patient’s primary care team, they can detect and address quality of life issues related to small intestine cancer and its treatments. This includes managing symptoms (such as pain, nausea and fatigue), adjusting to a new diet and lifestyle post-treatment (particularly if a large portion of the small intestine is removed) and being aware of possible long-term effects.
 
 
As one of a handful of institutes to attain the elite designation of Comprehensive Cancer Center by the National Cancer Institute, City of Hope is acknowledged as a leader in small intestine cancer research and treatment. With our decades of experience, specialized therapy protocols and extensive program of clinical trials, newly diagnosed or relapsed patients can find a treatment regimen that is tailored to their needs and gives them the best chance for survival. U.S. News & World Report also named City of Hope as one of the top cancer hospitals in the country.
 
 
In collaboration with other departments and cancer centers, City of Hope’s small intestine cancer program has an active portfolio of clinical trials studying novel treatments, including trials of new surgery, radiation and drug therapy regimens that are more effective against the disease and/or less harmful to the patient. Many of these promising therapies are only available to patients being treated at City of Hope.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Team

About Small Intestine Cancer

Small intestine cancer is characterized by malignant (abnormal and uncontrollably dividing) cells in the small intestine, a digestive organ responsible for absorbing nutrients from consumed food and beverages.
 
Small intestine cancer can fall into one of five types, based on the type of cells it arose from:
 
  • Adenocarcinoma, from mucus-secreting gland cells
  • Sarcoma, from muscle or connective tissue cells
  • Carcinoid tumors , from neuroendocrine cells
  • Gastrointestinal stromal tumors (GIST), from interstitial cells of Cajal, which regulate food digestion
  • Lymphoma

Signs and Symptoms of Small Intestine Cancer
 
Symptoms of small intestine cancers include:
 
  • Stools that are bloody or dark
  • Feeling discomfort, pain or fullness in the abdomen
  • Anemia
  • Unexplained weight loss
  • Fatigue and weakness
 
While many of these symptoms may be caused by other conditions, early small intestine cancer detection is crucial to successful treatment. If you or a loved one experiences any of the above symptoms, please contact a doctor for further evaluation.
 
Risk Factors of Small Intestine Cancer
 
Risk factors associated with small intestine cancer include:
 
  • Diet: A diet high in fat may elevate small intestine cancer risk, while a diet in fiber is linked with a lower risk
  • Diseases and Conditions:
    • Celiac disease: When people with celiac disease consume gluten (a protein found in wheat and several other types of grain), the body produce an immune reaction that attack intestinal tissues that can lead to cancerous changes
    • Colorectal cancer: Colorectal cancer survivors are at a higher risk for small intestine cancer
    • Genetic Conditions: Inherited gene mutations that are passed from parents to children can significantly raise small intestine cancer risk. These include familial adenomatous polyposis (FAP), hereditary non-polyposis colon cancer (HNPCC or Lynch syndrome), cystic fibrosis, Peutz-Jeghers syndrome and MUTYH-associated polyposis
    • Inflammatory Bowel Disease: Also known as Crohn’s disease or ulcerative colitis, this condition is characterized by long-term inflammation of the digestive tract, which can cause cellular changes that lead to small intestine cancer
  • Heavy alcohol use: Some studies found that excessive alcohol consumption (more than 2 drinks a day for men or 1 drink a day for women) raises small intestine cancer risk
  • Tobacco Use: Some studies link smoking to a higher small intestine cancer risk
 
If you suspect that you or a loved one may have an elevated risk of small intestine cancer, please consult with a doctor on preventive and early detection measures that are available.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

How We Diagnose and Stage Small Intestine Cancer

Diagnosing Small Intestine Cancer
 
A timely and accurate detection of small intestine cancer is essential to planning the best course of treatment. In addition to a routine physical examination and blood tests, City of Hope doctors may also use the following tests to diagnose small intestine cancer:
 
  • 3D computed tomography (CT) scan: Using advanced imaging technology and specialized techniques, radiologists at City of Hope can obtain highly precise images of the small intestine. This allows the care team to better detect and locate tumors they can be targeted with minimal impact on surrounding normal tissues.
  • Endoscopy: In this procedure, a flexible tube is inserted through the mouth and into the small intestine. A camera is attached to the tip of the tube, which can then take images of the small intestine lining. The endoscope may also be equipped with a tool to extract suspicious tissues for further evaluation.
  • Barium X-rays: Also called an upper GI series, a silver-white metallic compound is administered orally or directly in the small intestine. This compound coats the small intestine lining and allows for better visualization of abnormalities when X-rays are taken.
  • Biopsy: Abnormal-looking cells are extracted from the small intestine and checked by a pathologist for cancerous signs. Imaging tests may be used guide the biopsy to ensure accuracy.
  • Genetic testing: A genetic test of the cells extracted during biopsy can show whether the cancer is sensitive or resistant to specific treatments, so your care team can plan the most effective regimen against the disease.
 
Other tests that may be used for diagnosis or further evaluation include magnetic resonance imaging (MRI), positron emission tomography (PET) and ultrasound scans.
 
Staging Small Intestine Cancer
 
To properly plan for treatment, small cancer patients are staged in accordance to how advanced the disease is. This is primarily done by taking a number of factors into consideration, including:
 
  • Size of the tumor
  • If the tumor has grown into a blood vessel or adjacent organs, such as the stomach or colon
  • Whether the cancer has spread to nearby lymph nodes and how many lymph nodes are affected
  • Whether the cancer has metastasized to distant organs
  • If the tumor can be completely removed by surgery
 
Based on these factors, patients are staged according to their risk level, with higher risk patients typically requiring more intensive treatments.
 
More information on small intestine cancer staging criteria is available on the National Cancer Institute’s website.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Our Treatment Approach to Small Intestine Cancer

City of Hope has one of the most renowned small intestine cancer programs in the United States, with a multidisciplinary team of medical experts across different fields including surgery, radiation oncology, medical oncology and supportive care medicine. Together, they work collaboratively to plan and implement a treatment regimen that is individually tailored to the patient to improve survival chances, enhance outcomes and boost quality of life.

Surgery

Surgery is often the primary treatment for small intestine cancer, and it can be curative for early stage patients and can also improve survival outcomes and reduce discomfort for later stage patients.
 
City of Hope’s surgeons specialize in minimally invasive and robotically-assisted surgical procedures to treat small intestine cancer. By using smaller incisions compared to an open procedure, patients experience less pain, recover faster, have shorter hospital stays and are less likely to have post-surgical complications.
 
The expertise of City of Hope’s surgeons also means that they can treat small intestine cancers that are considered inoperable elsewhere. This is done through advanced procedures that can navigate around sensitive areas (such as major blood vessels) and working with radiation and medical oncologists, who may be able to shrink the tumor to down to an operable size and shape with radiation and drug therapies.
 
Surgery may also be performed to alleviate symptoms associated with small intestine cancer, such as a tumor obstructing digestive flow.
 

Radiation Therapy

Radiation can be used alone or in conjunction with other therapies to treat small intestine cancer by killing cancer cells or preventing the tumor growing larger. It is applied externally using one or more radioactive beams focused on the tumor.
 
Radiation therapy can also improve quality of life by relieving pain and stopping bleeds.
 
In addition to standard radiation regimens, City of Hope also offers Helical TomoTherapy, an advance technology combining radiation delivery with advanced imaging. This allows the radiation beams to be “sculpted” to the tumor’s size and shape, resulting in more focused radiation on the cancer site while minimizing exposure to adjacent tissues and organs.
 

Drug Therapy

City of Hope uses a wide range of chemotherapy and targeted therapy drugs to treat localized and metastatic small intestine cancer. In addition to standard drug regimens, patients have access to newly developed drugs (or drug combinations) through our clinical trials program.
 
Cancer fighting drugs can also enhance the effectiveness of surgery or radiation therapy, by shrinking the tumor before the procedure and making it easier to remove (neoadjuvant therapy), or given after the procedure to minimize the chance of recurrence (adjuvant therapy.)
 
Chemotherapy may also be given alongside radiation therapy to enhance the cancer-fighting effectiveness of both (chemoradiation.)
 
As part of the treatment team, a medical oncologist will evaluate the patient’s cancer, health and other factors, so that the chemotherapy, if appropriate, can be tailored to the patient throughout the continuum of care.
 

Become a Patient

If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Research and Clinical Trials

There is extensive collaboration between City of Hope clinicians and researchers to develop and evaluate new small intestine cancer therapies designed to improve survival and quality of life outcomes. City of Hope patients have access to a wide variety of clinical trials ranging from new chemotherapy and targeted therapies, novel surgical techniques and new radiation approaches — all focused on enhancing  treatment, detection and prevention of small intestine cancer.
 
  • Overexpression of the CEA protein in some intestinal cancers can be exploited for imaging purposes, since they will take in more of the drug M5A (which targets CEA-positive cancers) than normal tissues. Using this knowledge, researchers are investigating whether linking M5A to imaging agent 64Cu results in better visualization of tumors in a positron emission tomography (PET) scan.
  • Getting diagnosed with, and treatment for, small intestine cancer can have a profound impact on the patient’s caregivers as well. City of Hope researchers are currently studying this impact and whether a caregiver intervention program, consisting of home education and telephone support sessions, can help alleviate stress and boost quality of life.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Living with Small Intestine Cancer

While our primary goal is to cure or control the disease, another top priority is relieving suffering and discomfort for small intestine cancer patients undergoing cancer treatments.
 
In addition to curative treatments, City of Hope small intestine cancer patients and their caregivers have access to the broad range of services offered by our Department of Supportive Care Medicine. The department’s staff of professionals, including registered dieticians, rehabilitation specialists, supportive medicine physicians and clinical social workers, can help patients and loved ones with a variety of care and wellness issues including:
 
  • Managing small intestine cancer or treatment effects such as pain, nausea and fatigue
  • Palliative care to reduce discomfort and stress, physical and mental, throughout diagnosis and treatment
  • Adjusting to new dietary and lifestyle habits following small intestine cancer treatment
  • Coping and maintaining emotional/social/spiritual well-being
  • Navigating through the health care system
  • Staying healthy and active during/after treatment
  • Healing arts
  • Building caregivers’ skills  
 
The Department of Supportive Care Medicine is based in City of Hope’s Sheri & Les Biller Patient and Family Resource Center, which integrates all support services in a central location. The Biller Resource Center provides a warm and welcoming space where patients, families and caregivers can access the resources, education and support they need to strengthen and empower themselves, before, during and after treatment.
 
For more information or to contact the Biller Resource Center staff, please call 626-256-4673, ext. 32273 (3CARE).
 
 
This site includes tips, tools and online resources to help cancer patients and their families with issues that arise during cancer treatment.
 
Additional Resources

 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts more than 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Joe Komsky
Senior Development Officer
Phone: 626-218-6291
Email: jkomsky@coh.org

 
 

Small Intestine Cancer

Small Intestine Cancer

Although small intestine cancer is relatively rare in United States, it can be challenging to diagnose and treat. Thus, early detection and prompt medical care is crucial for optimal outcomes with minimal side effects.
 
City of Hope has one of the most experienced small intestine cancer programs in the United States, with a multidisciplinary team that takes an integrated approach to detecting and treating cancer of the small intestine. This includes using advanced technologies and specialized techniques such as:

  • minimally-invasive, robotically-assisted techniques for complex surgeries that can remove tumors with less discomfort, reduced risk of complications and shorter recovery times
  • highly precise radiation therapy that can target hard-to-resect tumors with minimal exposure to surrounding normal tissue
  • targeted drugs and drug combinations that can treat advanced small intestine cancer with greater effectiveness and fewer side effects, compared to traditional chemotherapy
  • combination regimens integrating surgery, radiation, chemotherapy and immunotherapy for maximum cancer-fighting effectiveness
 
Additionally, City of Hope patients have access to our extensive team of supportive care experts — including dieticians, supportive medicine physicians and rehabilitation specialists. Working closely with the patient’s primary care team, they can detect and address quality of life issues related to small intestine cancer and its treatments. This includes managing symptoms (such as pain, nausea and fatigue), adjusting to a new diet and lifestyle post-treatment (particularly if a large portion of the small intestine is removed) and being aware of possible long-term effects.
 
 
As one of a handful of institutes to attain the elite designation of Comprehensive Cancer Center by the National Cancer Institute, City of Hope is acknowledged as a leader in small intestine cancer research and treatment. With our decades of experience, specialized therapy protocols and extensive program of clinical trials, newly diagnosed or relapsed patients can find a treatment regimen that is tailored to their needs and gives them the best chance for survival. U.S. News & World Report also named City of Hope as one of the top cancer hospitals in the country.
 
 
In collaboration with other departments and cancer centers, City of Hope’s small intestine cancer program has an active portfolio of clinical trials studying novel treatments, including trials of new surgery, radiation and drug therapy regimens that are more effective against the disease and/or less harmful to the patient. Many of these promising therapies are only available to patients being treated at City of Hope.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Team

Small Intestine Cancer Team

About Small Intestine Cancer

About Small Intestine Cancer

Small intestine cancer is characterized by malignant (abnormal and uncontrollably dividing) cells in the small intestine, a digestive organ responsible for absorbing nutrients from consumed food and beverages.
 
Small intestine cancer can fall into one of five types, based on the type of cells it arose from:
 
  • Adenocarcinoma, from mucus-secreting gland cells
  • Sarcoma, from muscle or connective tissue cells
  • Carcinoid tumors , from neuroendocrine cells
  • Gastrointestinal stromal tumors (GIST), from interstitial cells of Cajal, which regulate food digestion
  • Lymphoma

Signs and Symptoms of Small Intestine Cancer
 
Symptoms of small intestine cancers include:
 
  • Stools that are bloody or dark
  • Feeling discomfort, pain or fullness in the abdomen
  • Anemia
  • Unexplained weight loss
  • Fatigue and weakness
 
While many of these symptoms may be caused by other conditions, early small intestine cancer detection is crucial to successful treatment. If you or a loved one experiences any of the above symptoms, please contact a doctor for further evaluation.
 
Risk Factors of Small Intestine Cancer
 
Risk factors associated with small intestine cancer include:
 
  • Diet: A diet high in fat may elevate small intestine cancer risk, while a diet in fiber is linked with a lower risk
  • Diseases and Conditions:
    • Celiac disease: When people with celiac disease consume gluten (a protein found in wheat and several other types of grain), the body produce an immune reaction that attack intestinal tissues that can lead to cancerous changes
    • Colorectal cancer: Colorectal cancer survivors are at a higher risk for small intestine cancer
    • Genetic Conditions: Inherited gene mutations that are passed from parents to children can significantly raise small intestine cancer risk. These include familial adenomatous polyposis (FAP), hereditary non-polyposis colon cancer (HNPCC or Lynch syndrome), cystic fibrosis, Peutz-Jeghers syndrome and MUTYH-associated polyposis
    • Inflammatory Bowel Disease: Also known as Crohn’s disease or ulcerative colitis, this condition is characterized by long-term inflammation of the digestive tract, which can cause cellular changes that lead to small intestine cancer
  • Heavy alcohol use: Some studies found that excessive alcohol consumption (more than 2 drinks a day for men or 1 drink a day for women) raises small intestine cancer risk
  • Tobacco Use: Some studies link smoking to a higher small intestine cancer risk
 
If you suspect that you or a loved one may have an elevated risk of small intestine cancer, please consult with a doctor on preventive and early detection measures that are available.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Diagnosing Small Intestine Cancer

How We Diagnose and Stage Small Intestine Cancer

Diagnosing Small Intestine Cancer
 
A timely and accurate detection of small intestine cancer is essential to planning the best course of treatment. In addition to a routine physical examination and blood tests, City of Hope doctors may also use the following tests to diagnose small intestine cancer:
 
  • 3D computed tomography (CT) scan: Using advanced imaging technology and specialized techniques, radiologists at City of Hope can obtain highly precise images of the small intestine. This allows the care team to better detect and locate tumors they can be targeted with minimal impact on surrounding normal tissues.
  • Endoscopy: In this procedure, a flexible tube is inserted through the mouth and into the small intestine. A camera is attached to the tip of the tube, which can then take images of the small intestine lining. The endoscope may also be equipped with a tool to extract suspicious tissues for further evaluation.
  • Barium X-rays: Also called an upper GI series, a silver-white metallic compound is administered orally or directly in the small intestine. This compound coats the small intestine lining and allows for better visualization of abnormalities when X-rays are taken.
  • Biopsy: Abnormal-looking cells are extracted from the small intestine and checked by a pathologist for cancerous signs. Imaging tests may be used guide the biopsy to ensure accuracy.
  • Genetic testing: A genetic test of the cells extracted during biopsy can show whether the cancer is sensitive or resistant to specific treatments, so your care team can plan the most effective regimen against the disease.
 
Other tests that may be used for diagnosis or further evaluation include magnetic resonance imaging (MRI), positron emission tomography (PET) and ultrasound scans.
 
Staging Small Intestine Cancer
 
To properly plan for treatment, small cancer patients are staged in accordance to how advanced the disease is. This is primarily done by taking a number of factors into consideration, including:
 
  • Size of the tumor
  • If the tumor has grown into a blood vessel or adjacent organs, such as the stomach or colon
  • Whether the cancer has spread to nearby lymph nodes and how many lymph nodes are affected
  • Whether the cancer has metastasized to distant organs
  • If the tumor can be completely removed by surgery
 
Based on these factors, patients are staged according to their risk level, with higher risk patients typically requiring more intensive treatments.
 
More information on small intestine cancer staging criteria is available on the National Cancer Institute’s website.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Treatment Options

Our Treatment Approach to Small Intestine Cancer

City of Hope has one of the most renowned small intestine cancer programs in the United States, with a multidisciplinary team of medical experts across different fields including surgery, radiation oncology, medical oncology and supportive care medicine. Together, they work collaboratively to plan and implement a treatment regimen that is individually tailored to the patient to improve survival chances, enhance outcomes and boost quality of life.

Surgery

Surgery is often the primary treatment for small intestine cancer, and it can be curative for early stage patients and can also improve survival outcomes and reduce discomfort for later stage patients.
 
City of Hope’s surgeons specialize in minimally invasive and robotically-assisted surgical procedures to treat small intestine cancer. By using smaller incisions compared to an open procedure, patients experience less pain, recover faster, have shorter hospital stays and are less likely to have post-surgical complications.
 
The expertise of City of Hope’s surgeons also means that they can treat small intestine cancers that are considered inoperable elsewhere. This is done through advanced procedures that can navigate around sensitive areas (such as major blood vessels) and working with radiation and medical oncologists, who may be able to shrink the tumor to down to an operable size and shape with radiation and drug therapies.
 
Surgery may also be performed to alleviate symptoms associated with small intestine cancer, such as a tumor obstructing digestive flow.
 

Radiation Therapy

Radiation can be used alone or in conjunction with other therapies to treat small intestine cancer by killing cancer cells or preventing the tumor growing larger. It is applied externally using one or more radioactive beams focused on the tumor.
 
Radiation therapy can also improve quality of life by relieving pain and stopping bleeds.
 
In addition to standard radiation regimens, City of Hope also offers Helical TomoTherapy, an advance technology combining radiation delivery with advanced imaging. This allows the radiation beams to be “sculpted” to the tumor’s size and shape, resulting in more focused radiation on the cancer site while minimizing exposure to adjacent tissues and organs.
 

Drug Therapy

City of Hope uses a wide range of chemotherapy and targeted therapy drugs to treat localized and metastatic small intestine cancer. In addition to standard drug regimens, patients have access to newly developed drugs (or drug combinations) through our clinical trials program.
 
Cancer fighting drugs can also enhance the effectiveness of surgery or radiation therapy, by shrinking the tumor before the procedure and making it easier to remove (neoadjuvant therapy), or given after the procedure to minimize the chance of recurrence (adjuvant therapy.)
 
Chemotherapy may also be given alongside radiation therapy to enhance the cancer-fighting effectiveness of both (chemoradiation.)
 
As part of the treatment team, a medical oncologist will evaluate the patient’s cancer, health and other factors, so that the chemotherapy, if appropriate, can be tailored to the patient throughout the continuum of care.
 

Become a Patient

If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Small Intestine Cancer Research

Small Intestine Cancer Research and Clinical Trials

There is extensive collaboration between City of Hope clinicians and researchers to develop and evaluate new small intestine cancer therapies designed to improve survival and quality of life outcomes. City of Hope patients have access to a wide variety of clinical trials ranging from new chemotherapy and targeted therapies, novel surgical techniques and new radiation approaches — all focused on enhancing  treatment, detection and prevention of small intestine cancer.
 
  • Overexpression of the CEA protein in some intestinal cancers can be exploited for imaging purposes, since they will take in more of the drug M5A (which targets CEA-positive cancers) than normal tissues. Using this knowledge, researchers are investigating whether linking M5A to imaging agent 64Cu results in better visualization of tumors in a positron emission tomography (PET) scan.
  • Getting diagnosed with, and treatment for, small intestine cancer can have a profound impact on the patient’s caregivers as well. City of Hope researchers are currently studying this impact and whether a caregiver intervention program, consisting of home education and telephone support sessions, can help alleviate stress and boost quality of life.
 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Living with Small Intestine Cancer

Living with Small Intestine Cancer

While our primary goal is to cure or control the disease, another top priority is relieving suffering and discomfort for small intestine cancer patients undergoing cancer treatments.
 
In addition to curative treatments, City of Hope small intestine cancer patients and their caregivers have access to the broad range of services offered by our Department of Supportive Care Medicine. The department’s staff of professionals, including registered dieticians, rehabilitation specialists, supportive medicine physicians and clinical social workers, can help patients and loved ones with a variety of care and wellness issues including:
 
  • Managing small intestine cancer or treatment effects such as pain, nausea and fatigue
  • Palliative care to reduce discomfort and stress, physical and mental, throughout diagnosis and treatment
  • Adjusting to new dietary and lifestyle habits following small intestine cancer treatment
  • Coping and maintaining emotional/social/spiritual well-being
  • Navigating through the health care system
  • Staying healthy and active during/after treatment
  • Healing arts
  • Building caregivers’ skills  
 
The Department of Supportive Care Medicine is based in City of Hope’s Sheri & Les Biller Patient and Family Resource Center, which integrates all support services in a central location. The Biller Resource Center provides a warm and welcoming space where patients, families and caregivers can access the resources, education and support they need to strengthen and empower themselves, before, during and after treatment.
 
For more information or to contact the Biller Resource Center staff, please call 626-256-4673, ext. 32273 (3CARE).
 
 
This site includes tips, tools and online resources to help cancer patients and their families with issues that arise during cancer treatment.
 
Additional Resources

 
 
If you have been diagnosed with small intestine cancer or are looking for a second opinion consultation about your treatment, find out more about  becoming a patient by calling 800-826-HOPE or filling out the Request a New Patient Appointment Online form.
 

Support This Program

Support this program

It takes the help of a lot of caring people to make hope a reality for our patients. City of Hope was founded by individuals' philanthropic efforts more than 100 years ago. Their efforts − and those of our supporters today − have built the foundation for the care we provide and the research we conduct. It enables us to strive for new breakthroughs and better therapies − helping more people enjoy longer, better lives.

For more information on supporting this specific program, please contact us below.

Joe Komsky
Senior Development Officer
Phone: 626-218-6291
Email: jkomsky@coh.org

 
 
Quick Links
With Cancer, Expertise Matters

 
Cancer patients need to have confidence in their treatment plans by exploring all possible options. Often that means they should get a second opinion. For these four patients, getting a second opinion from experts at City of Hope was life-saving.
Supportive Care Calendar
 
With MyCityofHope your health information is right at your fingertips, anywhere, any time.


NEWS & UPDATES
  • For Lars Nijland, the reason to become a member of a bone marrow registry was simple. “I always thought there would be no easier way to save somebody’s life,” said the 24-year-old student at Germany’s University of Goettingen, who signed up for the registry during a drive on his campus. Nijland will have ...
  • No parent ever wants to see their child hurting or sick in any way. Joanne Cooper’s daughter Amanda wasn’t sick, though. She seemed healthy. Vibrant. A straight-A student whose only major health ailment had been bouts of stress-related nausea. Then a blood test revealed that Amanda – now 9 years old – had myelo...
  • Noe Chavez became animated when he recalled the story: “We were running a health event, screening folks for diabetes,” said the enthusiastic City of Hope population health researcher, “and this man comes over and starts talking to us about the trouble he’s having with his eyes. I spoke with him, listened ...
  • When Keith McKinny, 29, was first diagnosed with lymphoma and leukemia in 2010, the first person he thought of was former boyfriend Jason Mullins. The two hadn’t been in contact with each other for some time, but McKinny couldn’t think of anyone else with whom he wanted to be during that difficult period....
  • Yesenia Portillo’s search for a bone marrow donor started close to home. Her brother, sister and seven cousins all underwent testing, but none of them were a close enough match to donate the bone marrow stem cells she desperately needed for her transplant. Yesenia, now almost 16, had always been healthy and act...
  • Some of City of Hope’s most high-impact achievements have arisen from City of Hope’s globally recognized bone marrow transplant (BMT) program. The annual Karl G. Blume – Gerhard Schmidt Memorial Lecture in Transplantation Biology & Medicine — commemorating two of the most influential and revered...
  • Guido Marcucci, M.D., wants to put himself out of business. A respected clinician and esteemed basic and translational scientist, Marcucci joins City of Hope as co-director of the Gehr Family Center for Leukemia Research within the Hematologic Malignancies and Stem Cell Transplantation Institute. In this positi...
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...